Revolution Medicines, Inc. (RVMD)
100.52
-1.10
(-1.08%)
USD |
NASDAQ |
Mar 03, 16:00
100.52
0.00 (0.00%)
After-Hours: 20:00
Revolution Medicines Research and Development Expense (Annual) : 978.68M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 13.34B |
| Merck & Co., Inc. | 12.51B |
| AbbVie, Inc. | 8.249B |
| Insmed, Inc. | 771.09M |
| Travere Therapeutics, Inc. | 206.01M |